HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Atieh Pourbagheri-Sigaroodi Selected Research
Atieh Pourbagheri-Sigaroodi Research Topics
Disease
22
Neoplasms (Cancer)
04/2022 - 01/2018
6
Acute Promyelocytic Leukemia
01/2021 - 12/2018
5
COVID-19
01/2022 - 11/2020
5
Leukemia
11/2021 - 10/2018
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2021
2
Breast Neoplasms (Breast Cancer)
12/2021 - 01/2018
2
Multiple Myeloma
11/2021 - 01/2019
2
Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 03/2019
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
05/2020 - 10/2018
1
Acute Lung Injury
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Neuroinflammatory Diseases
11/2021
1
Lymphoma (Lymphomas)
11/2021
1
Lung Injury
08/2021
1
Virus Diseases (Viral Diseases)
08/2021
1
Head and Neck Neoplasms (Head and Neck Cancer)
06/2021
1
Squamous Cell Carcinoma of Head and Neck
01/2021
1
Myeloid Leukemia (Leukemia, Myelocytic)
01/2021
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1
Carcinogenesis
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2020
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1
Ovarian Neoplasms (Ovarian Cancer)
01/2020
1
Inflammation (Inflammations)
01/2020
Drug/Important Bio-Agent (IBA)
6
Arsenic Trioxide (Trisenox)
FDA Link
10/2020 - 01/2018
3
Pharmaceutical Preparations
IBA
04/2022 - 10/2020
3
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2021 - 12/2018
3
NVP-BKM120
IBA
01/2020 - 12/2018
2
Immune Checkpoint Inhibitors
IBA
12/2021 - 10/2021
2
MicroRNAs (MicroRNA)
IBA
12/2021 - 03/2019
2
Enzymes
IBA
11/2021 - 05/2020
2
Histone Deacetylases (Histone Deacetylase)
IBA
11/2021 - 05/2020
2
Histone Deacetylase Inhibitors
IBA
11/2021 - 05/2020
2
Biomarkers (Surrogate Marker)
IBA
06/2021 - 11/2020
2
Pioglitazone (Actos)
FDA Link
01/2021 - 01/2020
2
Toll-Like Receptor 4
IBA
01/2021 - 01/2020
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2021 - 01/2021
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2022
1
Dual-Specificity Phosphatases
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
Insulin (Novolin)
FDA Link
11/2021
1
Cytokines
IBA
06/2021
1
Antiviral Agents (Antivirals)
IBA
06/2021
1
Proteins (Proteins, Gene)
FDA Link
05/2021
1
Trypan Blue
FDA Link
01/2021
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Toll-Like Receptor Agonists
IBA
01/2021
1
Autoantigens
IBA
01/2021
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2021
1
PPAR gamma
IBA
01/2021
1
Panobinostat
IBA
05/2020
1
Interleukin-6 (Interleukin 6)
IBA
01/2020
1
4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamide
IBA
01/2020
1
ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylate
IBA
01/2020
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2020
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
03/2019
1
BIBR 1532
IBA
03/2019
1
carfilzomib
IBA
01/2019
1
Aprepitant (Emend)
FDA Link
10/2018
1
Neurokinin-1 Receptors (Neurokinin 1 Receptor)
IBA
10/2018
1
Hormones (Hormone)
IBA
01/2018
1
Melatonin
IBA
01/2018
1
Messenger RNA (mRNA)
IBA
01/2018
1
Caspase 3 (Caspase-3)
IBA
01/2018
1
Survivin
IBA
01/2018
Therapy/Procedure
14
Therapeutics
04/2022 - 01/2018
5
Immunotherapy
02/2022 - 01/2021
2
Drug Therapy (Chemotherapy)
01/2022 - 12/2018
1
Molecular Targeted Therapy
01/2022
1
Immunomodulation
08/2021
1
Radiotherapy
01/2021